At one point, MassRoots was flying high, raising millions of dollars from investors and attempting to become the first cannabis company listed on the Nasdaq.
Tag Archives: Securities and Exchange Commission
Legal pot sales rose a stunning 34% in 2016 to $6.7 billion across North America, according to Arcview Market Research. But with growth this rapid, there’s bound to be more than a few marijuana stock investments that will be left behind.
First Trust Portfolios filed an S-6 on May 3oth with the Securities and Exchange Commission for a Medical Cannabis Portfolio Series – FT 6766 that is seeking above average capital appreciation.
DENVER, May 24, 2017 /Weed Wire/ —MassRoots, Inc. (OTCQB: MSRT), a leading technology platform for the medical cannabis industry, is pleased to announce the Company has filed its quarterly report with the Securities and Exchange Commission (SEC) for the quarter ending March 31, 2017.
As of April 13, 2017, more than 10.4 million shares of Insys Therapeutics (NASDAQ: INSY) were sold short. That’s 44% of the marijuana stock’s float. Investors have clearly bet big against Insys, anticipating that the stock will sink.
Beyond the legal issues, the problem for investors is that the industry is filled with small publicly traded companies that are risky bets at best, and outright fraudulent at worst.
WASHINGTON, Sept. 16, 2016 /Weed Wire/ — The Securities and Exchange Commission today announced fraud charges in a scheme involving illegal stock sales and false financial filings of a company that makes containers for growing marijuana.
DENVER,Aug. 16, 2016 /Weed Wire/ — MassRoots (OTCQB: MSRT), one of the largest and most active technology platforms for cannabis consumers, will post its financial results for the second quarter ended June 30, 2016, after market close on Wednesday, August 17, 2016.